Related Experiment Video

Updated: Jun 15, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

TGF-beta1 signal pathway may contribute to rhabdomyosarcoma development by inhibiting differentiation

Shouli Wang1, Lingchuan Guo, Liang Dong

  • 1Department of Pathology, Soochow University School of Medicine, Suzhou, China. wangsoly112@hotmail.com

Cancer Science
|March 12, 2010
PubMed

Insights

Transforming growth factor-beta1 (TGF-beta1) overexpression drives rhabdomyosarcoma (RMS) growth. Inhibiting TGF-beta1 with short-hairpin RNA (shRNA) reduced tumor growth and promoted myogenic differentiation, suggesting TGF-beta1 as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Transforming growth factor-beta1 (TGF-beta1) and its downstream molecules are overexpressed in rhabdomyosarcoma (RMS).
  • The precise regulatory role of TGF-beta1 in RMS progression and differentiation remains incompletely understood.

Purpose of the Study:

  • To investigate the role of TGF-beta1 in RMS cell growth and differentiation.
  • To explore the potential of targeting the TGF-beta1 signaling pathway for RMS therapy.

Main Methods:

  • Gene silencing of TGF-beta1 using short-hairpin RNA (shRNA) in RD cells.
  • Assessment of cell growth, apoptosis (caspase-3, TUNEL assays), and myogenic differentiation markers (myogenin, myosin, desmin).
  • Analysis of TGF-beta1, TbetaRII, and Smad4 expression in RMS tissues compared to normal skeletal muscle.

Main Results:

  • TGF-beta1, TbetaRII, and Smad4 expression were significantly higher in RMS than in normal muscle, correlating with histological grade.
  • TGF-beta1 shRNA significantly inhibited RD cell growth and induced apoptosis.
  • TGF-beta1 inhibition promoted myogenic differentiation, evidenced by morphological changes and increased expression of myogenin, myosin, and desmin.

Conclusions:

  • TGF-beta1 signaling plays a crucial role in promoting RMS growth and suppressing myogenic differentiation.
  • Targeting the TGF-beta1 pathway represents a promising therapeutic strategy for inducing differentiation in rhabdomyosarcoma.

More Related Videos

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...